Prestige Wealth Management Group’s Integra LifeSciences IART Stock Holding History

Prestige Wealth Management Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-21	Closed	-$258	–	1015
2025 Q2	$258	Hold	21	–	–	﹤0.01%	978
2025 Q1	$462	Hold	21	–	–	﹤0.01%	941
2024 Q4	$477	Hold	21	–	–	﹤0.01%	973
2024 Q3	$382	Buy	+21	New	+$487	﹤0.01%	992
2024 Q2	–	Sell	-87	Closed	-$3.08K	–	1019
2024 Q1	$3.08K	Hold	87	–	–	﹤0.01%	674
2023 Q4	$3.79K	Hold	87	–	–	﹤0.01%	639
2023 Q3	$3.32K	Hold	87	–	–	﹤0.01%	651
2023 Q2	$3.58K	Buy	+87	New	+$4.19K	﹤0.01%	666
2020 Q4	–	Sell	-18	Closed	-$1K	–	982
2020 Q3	$1K	Hold	18	–	–	﹤0.01%	777
2020 Q2	$1K	Hold	18	–	–	﹤0.01%	779
2020 Q1	$1K	Buy	+18	New	+$945	﹤0.01%	762
2019 Q1	–	Sell	-18	Closed	-$1K	–	792
2018 Q4	$1K	Buy	+18	New	+$988	﹤0.01%	1033

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prestige Wealth Management Group's IART Position: Q3 2025 in Review

Prestige Wealth Management Group sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 21 shares — an estimated $258 sold.

Prestige Wealth Management Group first reported a position in IART in Q4 2018 and held it in 12 quarters. The position peaked at $3.79K in Q4 2023. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

Prestige Wealth Management Group reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
Prestige Wealth Management Group sold 21 Integra LifeSciences shares in Q3 2025, an estimated $258.
Prestige Wealth Management Group first reported a position in Integra LifeSciences in Q4 2018 and held it in 12 quarters.
Prestige Wealth Management Group's Integra LifeSciences position peaked at $3.79K in Q4 2023.
207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on Prestige Wealth Management Group's 13F filing for Q3 2025, filed 10 Nov 2025.